MYLAN AUSTRALIA — Vancomycin Importer Profile
Pharmaceutical Importer · #9 buyer for Vancomycin · $2.2M import value · 55 shipments · AUSTRALIA · DGFT Verified
MYLAN AUSTRALIA is the #9 importer of Vancomycin from India with $2.2M in import value and 55 verified shipments. MYLAN AUSTRALIA holds a 3.0% market share in Vancomycin imports based in AUSTRALIA. The company sources from 1 verified supplier across 22 formulations shipped to 1 country. Overall, MYLAN AUSTRALIA imports 3 pharmaceutical products worth $6.3M across 3 therapeutic categories.
MYLAN AUSTRALIA — Vancomycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vancomycin to MYLAN AUSTRALIA?
Verified from 55 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $2.2M | 55 | 100.0% |
MYLAN AUSTRALIA sources Vancomycin from 1 verified Indian supplier based on 55 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does MYLAN AUSTRALIA Compare to Nearest Vancomycin Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MYLAN INSTITUTIONAL INC | UNITED STATES | $4.4M | 88 | $50.0K |
| 5 | DR.FRIEDRICH EBERTH ARZNEIMITTEL | GERMANY | $3.3M | 69 | $47.5K |
| 9 | MYLAN AUSTRALIA ★ | AUSTRALIA | $2.8M | 55 | $50.0K |
| 3 | EVERSANA | UNITED STATES | $2.1M | 42 | $50.0K |
| 8 | HANSE SERVICE INTERNATIONALE | GERMANY | $1.7M | 34 | $50.0K |
MYLAN AUSTRALIA ranks #9 among 743 Vancomycin importers from India. Average shipment value of $50.0K compared to the market average of $36.8K. The closest competitors by value are MYLAN INSTITUTIONAL INC and DR.FRIEDRICH EBERTH ARZNEIMITTEL.
Where Does MYLAN AUSTRALIA Import Vancomycin To?
Destination countries from 55 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $2.2M | 55 | 100.0% |
MYLAN AUSTRALIA imports Vancomycin to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $2.2M.
What Vancomycin Formulations Does MYLAN AUSTRALIA Import?
| Formulation | Value | Shipments |
|---|---|---|
| VANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUSTR | $1.1M | 22 |
| VANCOMYCIN VIATRIS FOI 500MG 1S MYLAN AU | $144.9K | 3 |
| VANCOMYCIN VIATRIS FOI 1G-1S-MYLAN AUSTRBATCH NO:7608942 TAXABLE VALUE:4658754.48 | $100.0K | 2 |
| VANCOMYCIN VIATRIS FOI 1G-1S-MYLAN AUSTRBATCH NO:7608823 TAXABLE VALUE:4638132.78 | $100.0K | 2 |
| VANCOMYCIN VIATRIS FOI 500MG-1S-MYLANAUS/ BATCH NO:7609428 TAXABLE VALUE:4788537.72 | $55.3K | 3 |
| VANCOMYCIN VIATRIS FOI 500MG-1S MYLAN AU | $50.0K | 1 |
| VANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUS ( | $50.0K | 1 |
| VANCOMYCIN VIATRIS FOI 1G 1S MYL AUSTR ( | $50.0K | 1 |
| VANCOMYCIN VIATRIS FOI 1G-1S MYLAN AUSTR | $50.0K | 1 |
| VANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUST | $50.0K | 1 |
MYLAN AUSTRALIA imports 22 distinct Vancomycin formulations from India. The top formulation is VANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUSTR with 22 shipments worth $1.1M.
Regulatory Requirements: Importing Vancomycin into Australia
What MYLAN AUSTRALIA and other importers must comply with to import Vancomycin from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Vancomycin
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Vancomycin from India and How Much Does MYLAN AUSTRALIA Import?
India exported $27.4M worth of Vancomycin through 3,071 shipments from 318 suppliers to 140 countries, serving 743 buyers globally. MYLAN AUSTRALIA imports $2.2M of this total, accounting for 3.0% of India's Vancomycin exports with 55 shipments from AUSTRALIA. This is verified from 55 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for MYLAN AUSTRALIA's Vancomycin Imports?
MYLAN AUSTRALIA's average Vancomycin order value is $39.9K per consignment, based on 55 shipments totaling $2.2M. MYLAN AUSTRALIA is based in AUSTRALIA and ranks #9 among all Vancomycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vancomycin to MYLAN AUSTRALIA?
MYLAN AUSTRALIA sources Vancomycin from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($2.2M, 100.0%). This is based on 55 customs records.
How Does MYLAN AUSTRALIA Compare to Other Vancomycin Importers?
MYLAN AUSTRALIA ranks #9 among 743 Vancomycin importers from India with a 3.0% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($5.8M), MYLAN INSTITUTIONAL INC ($4.4M), DR.FRIEDRICH EBERTH ARZNEIMITTEL ($3.3M). MYLAN AUSTRALIA processed 55 shipments from AUSTRALIA.
About MYLAN AUSTRALIA
MYLAN AUSTRALIA imports 3 products worth $6.3M. Beyond Vancomycin, top products include Dexamethasone, Fluticasone. View the complete MYLAN AUSTRALIA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vancomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MYLAN AUSTRALIA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MYLAN AUSTRALIA's capped import value divided by total capped export value for Vancomycin across all Indian exporters.
- 5.Verified Records: This page is backed by 55 individual customs records matching MYLAN AUSTRALIA importing Vancomycin, covering 22 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 140+ countries, 743+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vancomycin Import Data for MYLAN AUSTRALIA
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN AUSTRALIA's Vancomycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN AUSTRALIA
Full Company Profile →
3 products · $6.3M total trade · 3 categories
MYLAN AUSTRALIA × Vancomycin
Verified from customs records
Company Overview
Top Products by MYLAN AUSTRALIA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MYLAN AUSTRALIA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vancomycin. For current order-level data, contact TransData Nexus.